It could be argued that, after falling to 2-4 and seeing many of the grand plans of this 2026 Dallas Cowboys team sit utterly deflated following a 23-13 loss to the Packers on Sunday night in Green Bay, coach Brian Schottenheimer was in an impossible situation. What to say to your NFL team, after a devastating loss in which you were dominated on both sides of the ball, in which any progress made on the defensive side of the ball in the second half was offset first by the defense's poor play in the first half and the offense's poor play overall?
But Schottenheimer did go to the podium for his press conference on Sunday night and was asked what he said to the team.
His message: "The effort is right, the fight is right, but mistakes are killing us. Repeating mistakes is not what we're about. But we've got to protect the football. Five turnovers in two games, not very good. Got to find the running game. That starts with myself and the offensive staff. Got to get off the field on third down on defense, whether that's penalties or losing 1-on-1s. So, we got to clean it up. Lost two games in a row, not playing well. Got to take a hard look at it. Starts with me."
It is hard to say that, given the level of talent on this team–on the offensive line, in the receiver's room, at quarterback, at running back–that mistakes alone are the problem. The Cowboys did play harder and more aggressively on Sunday in Green Bay, that was obvious. But that also raises the question of where that effort and aggressiveness was in Week 5 against the Buccaneers, as well as at other times this season?
And, it could be argued, that the tendency toward mistakes with penalties and turnovers are a symptom of poor preparation and discipline. That's part of effort, and part of fight. So, it's hard to say that it's mistakes alone that are holding the team back.

#sunday

Packers' Zaire Franklin shares a subtle warning about Green Bay's defense appeared first on ClutchPoints. Add ClutchPoints as a Preferred Source by clicking here.
Green Bay is 4-2 on the season heading into Week 7 in Detroit after a 23-13 home win over the Cowboys that included a blunt postgame ****** sment from coach Matt LaFleur. LaFleur wants his team to focus on the details, something Jordan Love did well and linebacker Zaire Franklin's defense also excelled at in Week 6.
Franklin spoke to Matt Schneidman of The Athletic after the game during which he gave a warning on the Packers' hungry defense.
"I think it's just a credit to who we can be…Obviously we've got a lot of things we can clean up but I feel like we are a defense on the rise, every week we continue to get better and better…We got some stuff to clean up but I think the ceiling is extremely high."
Watch sports LIVE with fuboTV (free trial)

#franklin #warning

Packers' Matt LaFleur laments shortcomings in SNF win vs. Cowboys appeared first on ClutchPoints. Add ClutchPoints as a Preferred Source by clicking here.
The Green Bay Packers improved to 4-2 on the season with a 23-13 home win over Dak Prescott's Cowboys that shed light on an NFL record the home team set. A worrisome Tucker Kraft injury put a damper on the win one week before a crucial road trip to play the Detroit Lions at Ford Field.
Afterward, Zach Kruse of the Packers Wire laid out what LaFleur thought of his team's missed opportunities in what could have been a more decisive win.
"We left a lot out there. We had opportunities to put our foot on their throat…Had penalties, drops. We have to play cleaner football," LaFleur said.
Watch sports LIVE with fuboTV (free trial)

#lafleur #matt #preferred

Excluding independents, it was the only non-conference matchup of Week 7.
For such a unique matchup this late in the season, it was bound to produce a unique result: South Florida defeated Kent State, 29-2.
Kent State became the first FBS team to score exactly two points since UMass did in a 20-2 loss to Florida Atlantic on Nov. 20, 2020.
The Golden Flashes led 2-0 after the first quarter Saturday night in Tampa. Immediately after a turnover on downs at the South Florida 3-yard line, Kent State managed to salvage some points through its defense. True freshman defensive end Dion'Dre Taylor stuffed USF running back D.J. Crowther in the end zone to hand the Golden Flashes their first lead against a non-conference FBS opponent since Sept. 9, 2023, when they led Arkansas 3-0.
It appeared as if Kent State would build on that early advantage. After the safety, the Golden Flashes drove down to the USF 1-yard line. Kent State lined up in a tush push formation, attempting a quarterback sneak to extend the lead. However, an unclean center-quarterback change left the ball on the floor, and former 5-star defensive end recruit C.J. Hicks scooped it up and ran 99 yards for his first career touchdown.

#Kent #conference #matchup

Manchester United secured a 1-1 draw with Leeds United at Elland Road.
The away side took the lead and silenced the home crowd when a neat move was finished off by Bryan Mbeumo, who scored his fourth goal of the season.
Nonetheless, United have had an issue keeping clean sheets all season, and Dominic Calvert-Lewin muscled his way into the box in the second half to give the home side a share of the points.
The Red Devils have now drawn four, won one, and lost two of their Premier League matches this season, and sit in 13th place in the league.
Commenting on the result while working for Sky Sports, the former United captain stated, "there's a depressed standard and a low expectation right now. But it'll feel like a stepping stone for Michael Carrick, and it'll feel like the first step on the ladder in the Premier League."

#season #premier #home

The Dallas Cowboys have residual problems coming from Sunday night's loss. On the field the Cowboys were beaten soundly by the Green Bay Packers, but they are now going to be dealing with problems off of it as well.
Head coach Brian Schottenheimer noted after the game that linebacker Dee Winters has an Achilles strain while KaVontae Turpin is dealing with a rib cartilage issue. He added that x-rays were positive in that sense.
Cowboys LB Dee Winters has an Achilles strain and WR KaVontae Turpin is dealing with a rib cartilage issue. X-rays clean.
Turpin left the game rather early and was just about immediately ruled out for overall context.
Winters' issue came later, after he recorded the first interception of the season for the defense, and his absence was certainly felt.

#cowboys

Martha Stewart may not have a private jet, but she's done very well for herself over the years.
The lifestyle guru, 85, appeared on the Tuesday, October 6 episode of David Rogier's Other People's Business podcast, where the MasterClass founder and CEO asked whether fellow businesswoman Kim Kardashian has ever come to her for advice.
"We've talked, but she doesn't need my advice," Stewart responded. "That group is really, really good, and I really admire it. You know she's flying around in a G5. I don't have a G5."
"Why don't you think that you have a private jet?" Rogier questioned, to which the TV personality explained, "Because I fell in a hole and I lost about a billion dollars in my legal problems. The lawyers took me to the cleaners, and they were horrible."
Paul Zimmerman/AdMedia/Newscom/The Mega Agency

#stewart #private

Amid reports of Sean "Diddy" Combs' "pampered" lifestyle in prison, his release date has been pushed back.
The rap music mogul, who is behind bars at New Jersey's FCI Fort Dix serving a 50-month federal prison sentence, is set for release on March 2, 2028, according to the U.S. Federal Bureau of Prisons' inmate records viewed by USA TODAY. The move comes days after that release date was set for Jan. 21, 2028.
USA TODAY has reached out to Combs' rep for comment.
The news also comes after NBC News' report about Combs' life behind bars, revealing the hip-hop producer apparently has fellow inmates cook and clean for him, give him massages, and has access to outside alcohol and a cellphone, considered contraband.

#release #behind

It took Michael Douglas and Kathleen Turner a minute to get on the same page about coming clean about their love affair from decades ago.
In his new memoir One **** uva Ride, Michael, 82, revealed that he and Turner, 72, had a secret romance while filming the 1984 flick Romancing the Stone in Mexico, during which he considered himself separated from his then-wife Diandra Douglas, according to an expert on the book obtained by People.
A source tells Examiner that "at first" the Wall Street actor's "decision to come clean didn't go over well" with the Body Heat actress.
"She's an incredibly private person these days, the last thing she wanted was for people to be talking about her **** life, even if [it] was 40 years ago," the source explains.
Beitia Archives / Digital Press Photos/Newscom/The Mega Agency

#douglas #source #romancing

Michael Jackson's estate reported about $20 million in benefits for his three children and his mother during 2024, according to an annual accounting obtained by TMZ.
The filing, submitted by executor John Branca, details spending for Prince Jackson, Paris Jackson, Bigi Jackson and Katherine Jackson, including bills paid on their behalf.
Prince's approximately $4.9 million tax bill accounted for most of his reported benefits.
Katherine's entries included $145 at Cordie Cakes, $242 for balloons and $400 for cleaning services.
Prince had the largest reported benefits total at approximately $6.4 million. Payments connected to a Chevron gas card were also listed among his expenses.

#million #prince #approximately

Barry Keoghan has built a career by choosing characters that are rarely easy to understand. The Irish actor can appear vulnerable in one film and deeply unsettling in the next, often bringing an unpredictable quality to his performances. His journey into acting was equally unconventional, beginning far from the traditional routes into the entertainment industry. A difficult childhood in Dublin shaped his early years, while an unexpected opportunity introduced him to acting. Since then, Keoghan has developed into an internationally recognized performer with roles spanning independent dramas, major blockbusters and psychological thrillers.
Born in Dublin, Keoghan experienced considerable instability while growing up. His mother struggled with drug addiction and died when he was young, and he and his brother spent several years in foster care before being raised largely by their grandmother and aunt. Despite his later success, Keoghan has spoken warmly about returning home and immediately slipping back into ordinary family life, joking that celebrity status does not excuse him from making his bed or cleaning up after himself.
His entrance into acting came almost by chance. As a teenager, Keoghan noticed a casting advertisement in a local shop window for the Irish crime film Between the Canals. He responded despite having little professional experience and eventually secured a role. Television work followed, including the Irish drama Love/Hate, helping him develop his craft and attract greater attention.
His international profile grew dramatically in 2017. Keoghan appeared in Christopher Nolan's Dunkirk as George Mills, a young civilian caught up in the evacuation of Allied soldiers from France. That same year, he delivered a very different performance opposite Colin Farrell and Nicole Kidman in Yorgos Lanthimos's The Killing of a Sacred Deer. As the mysterious Martin, Keoghan demonstrated the unnerving screen presence that would become one of his greatest strengths.
Rather than remaining within one genre, he continued moving between dramatically different projects. He entered the Marvel universe as Druig in Eternals, appeared in The Green Knight and gained major acclaim for Martin McDonagh's The Banshees of Inisherin. His performance as Dominic Kearney earned him a BAFTA and an Academy Award nomination for Best Supporting Actor.

#keoghan #irish #dublin #despite

Google and Constellation Energy announced a 20-year power purchase agreement on Tuesday to bring 890 megawatts of new nuclear capacity onto the PJM Interconnection grid, with Constellation committing more than $4.3 billion to fund the build-out.
The capacity will be generated through turbine, steam generator, and digital control system upgrades at 11 Constellation nuclear units in Illinois, Pennsylvania, and New Jersey, the companies said. The first uprate is expected to be delivered by 2028. The agreement is expected to sustain roughly 4,400 existing jobs and create approximately 7,200 new construction jobs during the building period.
Alongside the power purchase agreement, the companies entered into a separate 15-year energy supply agreement covering an additional 2,700 megawatts from Constellation's existing fleet in the PJM market, the company said.
"We're committed to meeting our growth responsibly by actively investing in clean, reliable power that brings new capacity to our nation's grids," Amanda Peterson Corio, global head of energy and power at Google, said in a statement. "Our agreement with Constellation to fund nuclear reactor uprates will strengthen the PJM grid, which serves 67 million people, all while protecting energy affordability and supporting local union jobs."
Joe Dominguez, chairman, president and CEO of Constellation, said in a statement that the collaboration "can serve as a model for how technology companies and the energy industry can work together to responsibly develop the digital economy."

#energy #capacity #Jobs

Vistra (VST) stock opened in the green on Monday following reports that President Donald Trump's administration is finalizing a massive federal support package for the clean energy company. Chris Wright, U.S. Energy Secretary, is set to visit its Perry Nuclear Power Plant to officially announce up to $4.2 billion in government-backed loans aimed at upgrading three of VST's nuclear facilities.
Despite today's rally, Vistra stock is trading about 12% below its price at the start of this year.
Why It's Time to Load Up on Broadcom Stock Before It Touches $523
NVO vs. LLY: Novo's CEO Says Confidence Is Gone. Lilly Is Winning 7 in 10 New Seniors.
Billionaire Mark Cuban Says One Man Taking a Pill From $13.50 to $750 Is Why He Started Cost Plus Drugs, 'How Can This One Guy Take Control Of This Drug'

#Monday

Gisele Bundchen is soaking up quality time with her family in New York City. The supermodel was recently photographed on a relaxed day out with her 13-year-old daughter, Vivian, and the two looked more alike than ever. Their easygoing style quickly caught the attention of fans online. From long, wavy hair to laid-back denim looks, the mother-daughter duo made a simple stroll look effortless. The sweet outing offered a rare glimpse into their everyday family life.
Gisele Bundchen and her daughter Vivian enjoyed a family day out in the city. According to an X post, Bundchen was joined by her husband, Joaquim Valente, and Vivian, whom she shares with ex-husband Tom Brady. The group strolled down a leafy, sunlit street while fallen leaves dotted the sidewalk. Photos show mother and daughter chatting as they walked, with Vivian glancing toward her mom. The mood looked calm, cheerful, and completely unhurried.
Bundchen kept her look casual and comfortable. She wore a classic white tank top with loose, wide-leg jeans in a soft blue wash. A dark leather belt with a gold buckle added a polished touch. She completed the outfit with sunglasses, chunky sneakers, and a slouchy dark shoulder bag.
Vivian wore a cropped black tank top with relaxed, light-wash jeans. She draped a cream knit layer over her shoulders and carried her phone as she walked. Cozy tan slip-on shoes finished her outfit. Like her mom, she wore her long hair down in loose waves.
Known for making simple basics look effortless, Bundchen seems to have passed on the secret to Vivian. Both leaned into relaxed denim and a simple palette of white, black, and faded blue. Good jeans, a clean top, and comfortable shoes made for a stylish yet practical outfit for a walk around the city.

#bundchen #wore

Sean "Diddy" Combs is headed back into solitary confinement, a day after a report described a prison life of massages, smuggled liquor, and contraband phones.
Staff at FCI Fort Dix are returning Combs to the facility's Special Housing Unit, according to TMZ, which was told the move came in direct response to this week's NBC News reporting on his alleged perks. Sources described the placement as typical procedure while prison officials run an investigation.
The report in question drew on four men who spent time in Combs' unit at the New Jersey prison. They said the mogul had other inmates making his bed, doing his laundry, and cleaning his toilet before he used it.
Sources also revealed to NBC News that inmates cooked for him on makeshift heating elements, turning out curry chicken, pizza and empanadas, and that others gave him Chinese-style massages. Thousands of dollars a month allegedly flowed into their commissary accounts.
COMPLEX SHOP: Shop the brands you love, anytime and anywhere. Uncover what's next. Buy. Collect. Obsess.

#shop

Aubrey O'Day doubts that being in prison will be effective for her former label head, Diddy.
With reports surfacing that the Bad Boy Records founder, real name Sean Combs, will once again have his prison release pushed up, this time to January 2028, O'Day also reacted to allegations that he's living a pampered life behind bars. According to what several former Fort Dix inmates told NBC News, the 56-year-old has paid to be cleaned and cooked for, along with getting massages.
"Thank you, Chloe [Melas] for doing this investigation," the vocalist posted on X in response to the story. "People should understand the difference between rehabilitation and a ****** vacation. The system is broken- this man will come back a worse criminal."
AubreyODay/X
The report spoke to four men from Diddy's unit. It alleges that the mogul had access to cellphones, antidepressants, and Hennessy.

#diddy #sean #january

It's clear that the Princess of Wales has entered her autumn style era. Now that October is upon us, the 44-year-old has embraced the seasonal change with a plethora of darker-toned items.
Last week, Kate hosted a secret tea party for Three Peaks Challenge participants and their families at Windsor Castle. The royal looked elegant in a chocolate brown-coloured belted dress by the famously English heritage label Burberry. The structured fit-and-flare silhouette offered a clean, monochromatic look.
A new item in Kate's wardrobe, the £1,760 tailored dress is cut in a fit-and-flare silhouette that's cinched in with a striking, gold twist-lock belt. It also has slip pockets, which Kate was spotted appearing to use at certain moments. The dress appears to be bespoke as the sleeves are three-quarter length, whereas the frock on the shelves featured capped sleeves.
The Princess of Wales hosted a very special tea party at Windsor Castle (@ Andrew Parsons / Kensington Palace)
A year earlier, Kate wore the very same dress, but in black. During the German State visit in 2025, the mother of three was pictured viewing exhibits from the Royal Collection relating to Germany in the Green Drawing Room at Windsor Castle, alongside her husband, Prince William.

#kate #castle #dress #hosted

A TikTok posted by creator eriniveson on July 14, 2026, shows her describing punishments she says her parents used during her childhood. The video drew over 8.7 million views and about 1.1 million likes at the time of publication.
The creator, who grew up with her mother and stepdad, begins with a trigger warning before describing what she calls "completely legal things" her parents did. "The things that I'm gonna tell you in this video are just downright cruel," she said.
She said that when something broke and no one confessed, the siblings lined up, and whoever was responsible took the punishment while the others watched. The TikToker said she often took the blame for her younger sisters so they would not get in trouble. She recalls that her stepdad usually did not carry out the corporal punishment himself, but had her mother do it when she was home and stood by to supervise.
She said her room was searched regularly. "Privacy was a privilege, not a right," she said. After her stepbrother lost $5, her parents believed she had taken it, emptied her drawers onto the floor, and made her clean up.
Even doing chores had strict rules. "Do it right or do it twice," the creator remembered. She put away dishes that had spots from the dishwasher, so her mother, who collected antique china, emptied every cabinet and buffet, and the TikToker said she had to hand-wash and dry all of it.

#tiktoker #describing #million #punishment

Sean "Diddy" Combs is reportedly spending thousands of dollars monthly to live a pampered life at Fort Dix federal prison.
According to NBC News, who spoke with four former inmates who were once in the same unit as the 56-year-old, Diddy has allegedly been paying inmates to cook, clean, and even give him massages. The former inmates claim he accessed contraband phones, antidepressants, and alcohol.
"This is not some normal s**t you see in jail. This is some rich ***** ," a former prisoner told NBC News. "It looks crazy, but again, it's Diddy."
"Pretty much the day he arrived, the party started," said another inmate source.
COMPLEX SHOP: Shop the brands you love, anytime and anywhere. Uncover what's next. Buy. Collect. Obsess.

#according

Dakota Johnson was a sight to behold in a Yana Matkivski set as she posed for promo ahead of her "Saturday Night Live" hosting debut. Recently, the actress stepped out in New York City, embodying minimalist glamour as always. Photos and videos of her from the promo shoot have already made the rounds online.
For the outing, Dakota Johnson turned heads in a stunning Yana Matkivski two-piece set. The sage-green satin top featured a structured, high-neck bodice designed with sharp cap sleeves that tapered cleanly into a fitted torso. The fabric converged at the hip into a cropped hem, framing the waistband of the matching skirt beneath it.
Furthermore, the Helen Mini Skirt revealed an exceptionally short hem that sat high on her thighs. Extending from the waistband, the satin fabric skimmed smoothly down her hips, falling softly over her legs as she walked.
The skirt also featured a fitted, straight-cut silhouette with no added volume or pleating. It hugged her hips before ending in a clean, minimalist line above the knee. The pairing blended structured tailoring with soft, fluid satin.
Johnson paired the set with serious sparkle, opting for Marlo Laz's Natasha Diamond Bracelet, a two-tone piece lined with round diamonds, priced at $26,000. On her finger, she added Jessica McCormack's 0.90ct Diamond Golden Snake Ring, valued at $33,500. Meanwhile, her beauty styling leaned into minimalist glamour to complement the muted tones of the set.

#dakota

For his first-ever fashion show, Martin Andrijasevic, one half of the fan-favorite content-creating duo Slushy Noobz, used a face wash. "I washed my face with a cleanser, which I don't do normally and I probably should, but I thought that this would be a great day to do it," he tells Teen Vogue. Hamzah Al-Emad, the other star of Slushy Noobz, commemorated the moment with deodorant and Chapstick. "Feeling confident," he adds.
Attending Acne Studios' Women's Spring Summer 2027 show at Paris Fashion Week, Andrijasevic and Al-Emad, were dressed by the brand and styled by Kim Russell. A pink polo and low-rise pinstripe pants, complete with the Camero shoulder bag, gave Andrijasevic's front row look a Y2K flair. Al-Emad similarly wore a 00s-inspired outfit with a faux fur-trimmed jacket and jeans in Acne Studios' signature distressed wash.
Teen Vogue caught up with Slushy Noobz as they got ready for the show, discussing everything from mogging to their fashion icons.
Martin: Because it's only the coolest thing ever. We like fashion. We dress up a lot.

#slushy #show #teen #vogue

Amanda Peet noticed something unusual months before learning she had breast cancer.
During an interview on Today on Thursday, October 1, Peet, 54, described the change she first felt about six months before her diagnosis.
"I was in my closet, I was probably putting something on and I felt a weird — it just didn't feel like normal skin, but it wasn't the frozen pea that everybody talks about," The Whole Nine Yards star said during her conversation with the show's coanchor Savannah Guthrie.
That unfamiliar feeling prompted Peet to seek medical attention. At the time, she believed the results meant everything was fine.
"I went and I even got an MRI and then they sent me away," she said. "So I thought I had a clean bill of health, but they were actually watching it."

#felt

On August 5, Cencora (NYSE:COR) reported results for its fiscal third quarter, which closed on June 30, and the headline numbers looked clean. Revenue rose 5.1% to $84.8 billion, adjusted earnings per share climbed 12.0% to $4.48, and management raised its full-year adjusted EPS outlook to $17.75 to $17.95. The company also repurchased $1 billion of its own stock during the quarter. But the profit story has moving parts, and a few of them pull in opposite directions.
Start with the gap between profit growth and sales growth. Adjusted operating income rose 17.0% while revenue grew only 5.1%. Much of the help came from gross profit, which jumped 23.2% on an adjusted basis as both segments contributed and the OneOncology acquisition in February lifted margins in the US business. In plain terms, adjusted gross margin widened 61 basis points to 4.16%, so the company keeps more gross profit from every dollar it sells.
The strength was not confined to one corner, either. US Healthcare Solutions grew operating income 15.9% on higher pharmaceutical sales and the OneOncology deal, while specialty volume to health systems and physician groups lifted its revenue. International Healthcare Solutions did better still, with operating income up 20.8% on strength in European distribution and global specialty logistics. Management also put cash to work, completing in one quarter the $1 billion of buybacks it had expected to finish by the close of calendar 2026. The board declared a $0.60 quarterly dividend as well, payable August 31, to holders of record on August 14.
Growth is costing more than it first appears. Adjusted operating expenses jumped 26.8%, faster than adjusted gross profit, because OneOncology brought expenses along with its profits. Even so, adjusted operating income amounts to just 1.46% of revenue, a thin cushion on a business this large. Financing adds weight too. Cencora funded part of the purchase with new senior notes plus variable-rate term loans, and net interest expense rose $58.9 million from a year earlier.
The sales mix carries its own drag. GLP-1 drugs for diabetes and weight loss are adding to revenue, but they earn lower gross margins, so each dollar of that growth is worth less to profit. Meanwhile, an oncology customer Cencora lost in 2025, and lower sales to a large mail order customer both held back US revenue, as did lower manufacturer prices on some brand pharmaceuticals. Cencora is also exploring strategic alternatives for a group of other businesses, and its April divestiture of US Consulting Services trimmed consulting sales.

#adjusted #revenue #august

On September 9, 2026, Reuters reported that Alphabet Inc. (NASDAQ:GOOGL)'s Google will invest at least €13 billion, or about $15.1 billion, in AI infrastructure in Finland over the next two years, its biggest European investment, including three new data centers and a 22-year deal for up to 50% of the output of one of Finland's two nuclear power plants. The agreement with Finnish utility Fortum is Google's first nuclear energy deal outside the United States, and Fortum's stock jumped as much as 15.5% on the news, its biggest gain in Europe that day.
Finland gives Alphabet Inc. (NASDAQ:GOOGL) a potentially more cost-efficient location for its expanding AI infrastructure. Google plans to invest at least €13 billion ($15.1 billion) in three new data centers and related infrastructure in Finland during 2027 and 2028. The country's cold climate can reduce the need for energy-intensive cooling. The investment will also help grid improvements, clean-energy projects and battery storage.
The 22-year nuclear power agreement gives Google greater control over a critical input for AI infrastructure. Google will purchase up to 50% of the electricity generated by Finland's Loviisa nuclear plant, providing a long-term source of low-carbon power for its data-center operations. The agreement also gives Fortum greater economic certainty to extend and upgrade the plant through 2050. Google and Fortum plan to explore more nuclear and renewable projects.
Alphabet has strong demand drivers that can justify investment in AI capacity. The firm has increased its 2026 global capital investment target to $195 billion-$205 billion as it seeks to capture growing AI computing demand. Google is using the additional infrastructure to support Gemini, Search, Maps, and YouTube. It gives Alphabet multiple major products through which it can monetize greater AI capacity over time.
The Finland project adds another major commitment to Alphabet Inc. (NASDAQ:GOOGL)'s already enormous AI spending program. Alphabet expects to spend $195 billion-$205 billion on capital investment globally in 2026. The Finnish project will require at least another €13 billion during 2027 and 2028. Investors need Alphabet to make enough incremental revenue and cash flow from AI services to justify an infrastructure buildout that is rapidly increasing the company's capital requirements.

#billion #Google #investment #googl

Definium Therapeutics, Inc. (NASDAQ:DFTX) has now delivered a third consecutive positive Phase 3 readout for its LSD-based medication, the second in generalized anxiety disorder. The result puts the company on a viable route toward a potential FDA approval of an LSD-based treatment for generalized anxiety disorder, and considering how closely psychedelic stocks have historically traded on each other's data, the reading carries far more weight than Definium's own ticker.
On September 14, Definium Therapeutics, Inc. (NASDAQ:DFTX) announced that its drug DT120, an orally disintegrating tablet formulation of LSD, was successful in Panorama, the company's second late-stage anxiety trial. Over 12 weeks, patients who received a 100-microgram dose experienced a 9.8-point decline on the Hamilton Anxiety Rating Scale, a typical clinical measure, compared to a 4.7-point drop with placebo.
The resulting 5.1-point placebo-adjusted improvement is similar to what the company's first pivotal anxiety trial, Voyage, showed back in August: an 11.6-point improvement versus 6.2 for placebo, a 5.4-point separation that Jefferies called one of the strongest placebo-adjusted efficacy results ever seen in generalized anxiety disorder, and that Stifel simply described as "a clean win."
Psychedelic equities have a history of trading as a group rather than as individual names, and this tendency applies both ways. In February 2026, when Compass Pathways, the sector's other clinical leader developing a psilocybin-based drug for treatment-resistant depression, reported positive late-stage data, shares of Definium Therapeutics, Inc. (NASDAQ:DFTX), Atai Beckley, GH Research, and Helus Pharma all rose, some by double digits.
That correlation is significant here because Definium's win is an independent validation of the broader therapeutic argument on which Compass and others are betting: a single dose of a classic psychedelic, administered in a controlled clinical setting, can produce lasting improvements in serious mental health conditions via pathways different from existing SSRIs and other standard-of-care drugs.

#definium #placebo

On September 14, NextEra Energy, Inc. (NYSE:NEE) and Dominion Energy, Inc. (NYSE:D) announced a "transformational" Virginia benefits package to address concerns regarding their proposed $66.8 billion merger. The Virginia supplier program, worth up to $1 billion annually ‌for five years, will direct spending toward contractors, suppliers, and service providers in the state.
Additionally, the companies also proposed doubling residential bill credits to four years, protecting retail customers from grid costs tied to Northern Virginia's rapidly expanding AI data centers, and committing $100 million toward directly supporting workforce development in the Commonwealth. NextEra also stated that it plans to add 600 new energy jobs in Virginia, while expecting suppliers to create another 400 positions.
The updated package comes after the proposed merger attracted a great deal of political scrutiny due to the impact it can have on everyday consumers. Virginia Governor Abigail Spanberger also stated last month that she would formally intervene in the regulatory review to press for commitments on electric bill affordability, job protections, and clean-energy investments.
John Ketchum, Chairman, President, and CEO of NextEra Energy, commented:
"This is a Virginia-first package, and it starts with customers. We are proposing to double residential bill relief from two years to four years, along with expanded low-income financial ******* istance and long-term affordability benefits. We are also reaffirming our support for the State Corporation Commission, Governor and General ******* embly's efforts to protect residential and small business customers from costs ******* ociated with serving data centers. Just as important, this package would help Virginia build more of the clean energy and infrastructure it needs faster, so the Commonwealth can reduce its reliance on expensive imported power. And it would do that while positioning Virginia as a major energy leader, bringing NextEra Energy jobs, good-paying supplier jobs, workforce investment, economic development and national-scale energy technology and innovation to Virginia. This is the kind of customer-focused, job-creating package this combination makes possible."

#energy #years #Jobs

On September 16, Air Products (NYSE:APD) said it had signed a long-term deal to supply high-purity gases to a leading chipmaker, backed by roughly $250 million of its own money in Arizona. It is the company's second semiconductor supply win, and the two projects together carry more than $900 million of investment. That is a notable turn for a company that has been pulling back from big clean-energy projects.
The Arizona project plays to what Air Products already does. It will build, own, and operate the equipment, from hydrogen generation units and carbon dioxide purification to bulk supply for three gases: helium, hydrogen, and carbon dioxide. That means the customer's gas supply runs through equipment Air Products owns. Supply is targeted to start in phases, so the buildout can move alongside the customer's expansion plans. And this is familiar ground. Air Products has supplied electronics makers for more than 40 years, and its Chandler facility has served the Phoenix chip cluster since 1981, with a pipeline system carrying ultra-high purity nitrogen around the area.
The core business gives the deal a solid floor. In the fiscal third quarter, reported on July 30, adjusted earnings per share rose 12% to $3.47, and management lifted its full-year outlook to an adjusted $13.39 to $13.49 per share. Margins widened as well, so growth is showing up as profit. Chips appear elsewhere in the results too, since the company announced a deal to build four large air separation units to serve a chipmaker's growth in Taiwan.
The cost of the pivot is hard to ignore. On June 30, Air Products announced it would not go ahead with its Louisiana Clean Energy Complex and would discontinue a zero-carbon liquid hydrogen facility in Casa Grande, Arizona, plus other smaller clean energy distribution projects. The exits triggered roughly $2.9 billion in pre-tax charges, which is why the company posted a GAAP loss of $6.47 per share in the third quarter even as its underlying earnings grew. Adjusted results leave that hit out, but the GAAP numbers show what the retreat cost.
Owning the ****** ets also means funding them. Air Products expects about $3.5 billion of capital spending in fiscal 2026, and the Arizona plant alone is a commitment of approximately $250 million, with supply arriving in phases. The release also leaves gaps: it does not name the customer or say how long the contract runs, so the length of the revenue stream is unclear. Elsewhere, Europe's operating income rose only 2% as costs climbed, and management says it is still cautious about the economic backdrop.

#clean #adjusted

If you're trying to build a consumer-focused corner of your portfolio that can grow through a lot of different economic backdrops, three names stand out right now: Church & Dwight Co. (NYSE: CHD), YETI Holdings (NYSE: YETI), and Newell Brands (NASDAQ: NWL). Each of these is making deliberate moves in 2026 and into 2027 that communicate to me more about their future than any single rocky quarter's earnings line.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Church & Dwight has built its identity on everyday products like baking soda, laundry detergents, and cleaners that quietly show up in millions of homes. In May 2026, it moved to deepen that footprint by buying the Miss Mouth's Messy Eater brand, a fast-growing, non-toxic stain remover built for parents. It's a small thing on paper, but it fits this successful company's patterns: Keep layering niche, repeat-use products into an existing distribution machine instead of chasing flashy new categories.
The company's first-quarter 2026 update backs that strategy up. Organic sales rose 5% even though reported net sales were basically flat due to past portfolio pruning, per company management. Management described 2026 as a year of "volume-driven" organic growth, meaning they're focused on selling more units to real customers, not just leaning on price increases. On top of that, Church & Dwight extended its long dividend record yet again. Although it is not quite a Dividend King, it has consistently raised its dividend for 29 years.
For investors, my advice here is straightforward: Treat Church & Dwight as a core holding in a consumer bucket. It's unlikely to deliver fireworks in a single year, but it keeps making acquisitions to deepen its understanding of existing categories.

#flashing #organic

Johnson & Johnson (JNJ) stock has returned about 57% over the past year, against about 17% for the S&P 500. On the earnings it has already banked, that price looks expensive. But those earnings carry STELARA, which is losing share to biosimilar competition. What looks dear on earnings already reported comes down sharply on the earnings ***** ysts expect.
At about $270 a share, Johnson & Johnson trades at about 28.3 times its trailing earnings. That figure sits on adjusted earnings: normalized net income with stock-based compensation added back, meant to sit closer to the basis ***** ysts use in their forecasts than a GAAP figure would, though the two measures are not defined identically. Measured as market value against consensus net income, the multiple on fiscal 2026 earnings is about 24.1 times, and on the earnings expected for 2027 it is about 20.9 times.
Those trailing twelve months were not a clean run. STELARA cost Johnson & Johnson about 460 basis points of operational sales growth in the second quarter of 2026. Strip it out and the company grew double digits in that quarter on the same basis, on management's own account.
The trailing multiple measures today's price against a period burdened by slowing STELARA revenue. The rest of the portfolio kept growing. Revenue over the trailing twelve months is close to $98 billion, and the company has 28 products and platforms that each sell more than $1 billion a year.
Immunology shows both sides at once. TREMFYA grew 71% in the second quarter of 2026, and it remains the fastest-growing advanced therapy in both Crohn's disease and ulcerative colitis. STELARA is shrinking under biosimilars in that same segment.

#johnson #earnings

On August 5, Cencora (NYSE:COR) reported results for its fiscal third quarter, which closed on June 30, and the headline numbers looked clean. Revenue rose 5.1% to $84.8 billion, adjusted earnings per share climbed 12.0% to $4.48, and management raised its full-year adjusted EPS outlook to $17.75 to $17.95. The company also repurchased $1 billion of its own stock during the quarter. But the profit story has moving parts, and a few of them pull in opposite directions.
Start with the gap between profit growth and sales growth. Adjusted operating income rose 17.0% while revenue grew only 5.1%. Much of the help came from gross profit, which jumped 23.2% on an adjusted basis as both segments contributed and the OneOncology acquisition in February lifted margins in the US business. In plain terms, adjusted gross margin widened 61 basis points to 4.16%, so the company keeps more gross profit from every dollar it sells.
The strength was not confined to one corner, either. US Healthcare Solutions grew operating income 15.9% on higher pharmaceutical sales and the OneOncology deal, while specialty volume to health systems and physician groups lifted its revenue. International Healthcare Solutions did better still, with operating income up 20.8% on strength in European distribution and global specialty logistics. Management also put cash to work, completing in one quarter the $1 billion of buybacks it had expected to finish by the close of calendar 2026. The board declared a $0.60 quarterly dividend as well, payable August 31, to holders of record on August 14.
Growth is costing more than it first appears. Adjusted operating expenses jumped 26.8%, faster than adjusted gross profit, because OneOncology brought expenses along with its profits. Even so, adjusted operating income amounts to just 1.46% of revenue, a thin cushion on a business this large. Financing adds weight too. Cencora funded part of the purchase with new senior notes plus variable-rate term loans, and net interest expense rose $58.9 million from a year earlier.
The sales mix carries its own drag. GLP-1 drugs for diabetes and weight loss are adding to revenue, but they earn lower gross margins, so each dollar of that growth is worth less to profit. Meanwhile, an oncology customer Cencora lost in 2025, and lower sales to a large mail order customer both held back US revenue, as did lower manufacturer prices on some brand pharmaceuticals. Cencora is also exploring strategic alternatives for a group of other businesses, and its April divestiture of US Consulting Services trimmed consulting sales.

#profit #operating #Growth #august